Schering Sees Growth Opportunity For Organon Products In The U.S. – Hassan
Executive Summary
Schering-Plough sees significant growth potential for Organon's products that currently are marketed in the U.S., CEO Fred Hassan said March 20
You may also be interested in...
FTC investigating Schering/Organon merger
The Federal Trade Commission is requesting additional information from Schering-Plough regarding its planned acquisition of Akzo Nobel's pharmaceutical and animal health business, Organon Biosciences. Despite FTC's request, Schering continues to expect the $14.4 billion transaction to be completed by the end of 2007 (1"The Pink Sheet" March 26, 2007, p. 25)...
FTC investigating Schering/Organon merger
The Federal Trade Commission is requesting additional information from Schering-Plough regarding its planned acquisition of Akzo Nobel's pharmaceutical and animal health business, Organon Biosciences. Despite FTC's request, Schering continues to expect the $14.4 billion transaction to be completed by the end of 2007 (1"The Pink Sheet" March 26, 2007, p. 25)...
Schering Jumps On Organon Buy; Will Late-Stage M&A Keep Fueling Pharma?
Pharmaceutical companies unveiling mergers and acquisitions in the first quarter were among those rewarded by Wall Street